Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$2.81
-7.43%
Mkt Cap $195.59M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+292.2%
Consensus $11.00 vs current $2.81
NASDAQ·Healthcare·Biotechnology
$2.81
-7.43%
Mkt Cap $195.59M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+292.2%
Consensus $11.00 vs current $2.81